Article
Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease.
Journal of molecular medicine (Berlin, Germany) - 1 May 2005
Gaede Karoline I, Amicosante Massimo, Schürmann Manfred, Fireman Elisabeth, Saltini Cesare, Müller-Quernheim Joachim
Abstract excerpt
Chronic beryllium disease (CBD) is a rare occupational, granulomatous lung disease clinically resembling sarcoidosis. The immune response to beryllium is thought to depend on genetic susceptibility. Although a glutamic acid in position 69 of the human leukocyte antigen-DP beta chain (HLA-DPB1-Glu69) is associated with the development of CBD, it cannot fully explain susceptibility. It is likely that additionally...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
